《中华高血压杂志》创刊30年载文被引情况及核心作者分析  

Analysis of the citations and core authors of the articles published in the Chinese Journal of Hypertension over the past 30 years since its inception

作　　者：刘莉 陈小明[1] 谢良地[1,2,3,4,5] LIU Li;CHEN Xiaoming;XIE Liangdi(Editorial Department of Chinese Journal of Hypertension,Journal Center,the First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian 350005,China;Department of Geriatrics,Fujian Hypertension Research Institute,the First Affiliated Hospital,Fujian Medical University,Fuzhou,Fujian 350005,China;Clinical Research Center for Geriatric Hypertension Disease of Fujian Province,the First Affiliated Hospital,Fujian Medical University;Branch of National Clinical Research Center for Geriatrics,the First Affiliated Hospital,Fujian Medical University;Department of Geriatrics,National Regional Medical Center,Binhai Cam pus of the First Affiliated Hospital,Fujian Medical University,Fuzhou,Fujian 350005,China)

机构地区：[1]福建医科大学附属第一医院期刊中心,中华高血压杂志编辑部,福建福州350005 [2]福建医科大学附属第一医院老年医学科,福建省高血压研究所,福建福州350005 [3]福建省老年高血压疾病临床医学研究中心 [4]国家老年疾病临床医学研究中心福建省分中心 [5]福建医科大学附属第一医院滨海院区国家区域医疗中心老年医学科,福建福州350005

出　　处：《中华高血压杂志（中英文）》2024年第6期550-556,共7页Chinese Journal of Hypertension

基　　金：福建医科大学附属第一医院院级课题(2022FY-R-15);中华预防医学会第二期期刊发展基金项目(精品期刊培育项目)。

摘　　要：目的分析1993-2022年《中华高血压杂志》载文被引情况,以探讨《中华高血压杂志》的整体学术质量,确定核心作者,提高期刊的学术水平。方法通过中国知网数据库(CNKI)检索1993-2022年发表在《中华高血压杂志》上的所有文献信息,于2023年7月5日通过中国知网数据库获得上述文献于1993-2022年被引用的相关数据。采用文献计量方法对《中华高血压杂志》的载文被引情况进行统计分析,主要指标包括年度发文被引率、篇均被引频次、作者被引情况、被引作者的地区和高产机构分布等,总结《中华高血压杂志》发展的客观规律和在高血压领域的影响程度,刊载论文的质量,文献的传播利用规律。应用普赖斯定律和综合指数确定核心作者。结果《中华高血压杂志》30年主要栏目共载文9730篇,其中被引篇数6306篇,占64.8%。总被引频次79172次,篇均被引8.14次。被引频次>200次的文章有17篇,以领域内指南为主(9篇,占52.94%),《中国高血压防治指南2010》是总被引频次最高的文章,总被引7734次。第一作者被引排名前10名发文总被引频次均>400次,这些作者分别来自医院、科研机构及医学院校。发文篇数最多和总被引频次、篇均被引频次最高的地区为北京。总被引频次最高的单位为福建医科大学附属第一医院;篇均被引频次最高的单位为国家心血管病中心。经过计算核心作者候选人平均发文量和平均被引用量,最终确定核心作者29位。结论《中华高血压杂志》刊发的文章及作者具有较高的学术影响力,但仍有优化管理的空间,需规划发展策略,以进一步提升杂志学术地位和科技影响力。Objective To analyze the citation status of articles published in the Chinese Journal of Hypertension(the Journal)from 1993 to 2022,in order to explore the overall academic quality of the journal,determine core au-thors,and improve the academic level of the journal.Methods All literature information published in the Journal from 1993 to 2022 were retrieved through the China National Knowledge Infrastructure database(CNKI).The cita-tion information of the literature being cited from 1993 to 2022 were obtained through the CNKI on July 5,2023.Statistical analysis was conducted on the citation status of articles published in the Journal using bibliometric meth-ods.The main indicators included annual citation rate,average citation frequency per article,author citation status,region of cited authors,and distribution of high-yield institutions.The objective laws of the development of the Jour-nal,the impact in the field of hypertension,as well as the quality of published papers and the laws of literature dis-semination and utilization were summarized.Price's law and comprehensive index were used to determine the core author.Results A total of 9730 articles had been published in the Journal over the past 30 years,of which 6306 were cited,accounting for 64.8%.The total citation frequency was 79172 times,with an average of 8.14 citations per article.There were 17 articles with a citation frequency greater than 200 times,mainly focusing on guidelines within the field(9 articles,accounting for 52.94%)."The Chinese Guidelines for the Prevention and Treatment of Hypertension 201o"had the highest total citation frequency,with 7734 citations.The total citation frequencies of articles written by the top 10 authors in first author's citation ranking were all above 40o times,and these authors came from hospitals,research institutions,and medical colleges.The region with the highest number of published articles,total citation frequency,and average citation frequency was Beijing.The author's affiliation with the highest total citatio

关 键 词：中华高血压杂志 被引频次 核心作者 文献计量学 

分 类 号：G237.5[文化科学] R-05[医药卫生]